Literature DB >> 2026474

Suppressive effect of anti-rheumatic drugs on interleukin-1 beta release from human peripheral blood monocytes.

M Okamoto1, M Sasano, M Goto, K Nishioka, S Aotsuka, K Nakamura, R Yokohari.   

Abstract

We developed an ELISA system for human IL-1 alpha and -beta release from silica-stimulated monocytes from healthy volunteers and tested the effect of several anti-rheumatic drugs including nonsteroidal anti-inflammatory drug (Ibuprofen). Anti-rheumatic drugs including Auranofin and Sulphasalazine suppressed IL-1 beta release significantly at therapeutic concentrations, whereas Bucillamine, Lobenzarit, D-Penicillamine and Ibuprofen did not. These results suggest a possible immunotherapeutic effectiveness of some anti-rheumatic drugs on rheumatoid arthritis through their inhibition of IL-1 beta release.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026474     DOI: 10.1016/0192-0561(91)90023-z

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  2 in total

1.  Complete prevention of the clinical expression of adjuvant-induced arthritis in rats by cyclosporin-A and lobenzarit: the regulation of lymph node cell populations and cytokine production.

Authors:  D R Haynes; S J Gadd; M W Whitehouse; G Mayrhofer; B Vernon-Roberts
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

2.  Sulphasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds.

Authors:  G Carlin; R Djursäter; G Smedegård
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.